Michael Wang, MD., Ph.D., member of AFCR Scientific Advisory Board On February 11, weeks into the COVID-19 outbreak, the novel coronavirus was officially called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), as most patients showed mild to severe respiratory illness. Doctors shared the same concept, based largely on commonly observed…...
Why Are Men More Vulnerable to COVID-19? Research Is Gradually Uncovering the Truth
Michael Wang, MD., Ph.D., member of AFCR Scientific Advisory Board Early in February, Dr. Sabra Klein, a professor in the Department of Molecular Microbiology and Immunology of the Johns Hopkins Bloomberg School of Public Health, noticed a sex difference in COVID-19 infections based on reports emerging from China. She felt…...
To Do the Therapy & MRI Follow-up or Not in the Midst of COVID-19 Pandemic: “New Normal” Treatment Guidelines for Brain Tumor Patients
Note: This is part two of Dr. Michael Wang’s series that specifically addresses Brain Cancer Treatment during the Coronavirus Pandemic. You can read part one here. Michael Wang, MD., Ph.D., member of AFCR Scientific Advisory Board In addition to surgery, radiation therapy and chemotherapy are the other two major medical procedures…...
To Do the Surgery or Not in the Midst of COVID-19 Pandemic: “New Normal” Treatment Guidelines for Brain Tumor Patients
Michael Wang, MD., Ph.D., member of AFCR Scientific Advisory Board With today being the first day of May, Brain Tumor Awareness Month, I wish to highlight for you a recently produced set of best practices and guidelines pertaining to brain cancer and COVID-19. Glioblastoma, also known as glioblastoma multiforme (GBM), is the…...
Colorectal Cancer: A Serious, But Preventable Disease
Colorectal cancer is a killer worldwide, claiming at least 500,000 lives every year. In Hong Kong, it is the most common of all cancers with over 5,000 new cases diagnosed annually. Although colorectal cancer can be a devastating disease, it is also very preventable thanks to the development of advanced…...
‘Should I Continue my Scheduled Cancer Treatment During the Coronavirus Pandemic?’ And Other Questions Answered
Michael Wang, MD., Ph.D., member of AFCR Scientific Advisory Board The total number of confirmed COVID-19 cases worldwide has surpassed 1.4 million. With varying public health responses across countries, there is still no clear prediction for when the number of cases will peak. This severe situation creates challenges for cancer patients…...
